After subcutaneous injection, a large number of M2 macrophages were significantly decreased, and the expression of programmed cell death protein ligand-1 (PD-L1) was increased, resulting in a vulnerable tumor microenvironment (TME) against subsequent chemotherapy.379. This evidence concerns the gene CD274 and neoplasm.